secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001104659-25-016711
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents raises $1.6M from Series A warrant exercises; total rights offering proceeds $7.85M
--------------------------------------------------------------------------------

- 1,417,208 Series A Right Warrants exercised at $1.13 each for $1.6M gross proceeds upon expiration.
- Total rights offering gross proceeds reached $7.85M; net liquidity increased by ~$12.3M after restricted cash released.
- Approximately 4.8M shares remain reserved for Series B Right Warrants, exercisable until April 10, 2025.
- CEO notes progress on DrugSorb-ATR regulatory applications with U.S. FDA and Health Canada, expecting decisions in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465925016711/0001104659-25-016711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465925016711/tm257523d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-016711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer